Vertex Q4 Earnings On Deck: Will This Biotech Heavyweight Keep Its Edge?
Vertex Pharmaceuticals (VRTX) reports Q4 earnings today. Investors are eager for updates on new drug launches and growth ...
CRN1y
Cohesity, Google Cloud Team Up For Vertex AI Data Protection
Cohesity is teaming with Google to apply Google’s generative AI platform Vertex AI to solve the complexity ... stores across on-premises, cloud, and edge environments. Sanjay Poonen Data ...
Benzinga.com15d
Vertex Pharmaceuticals Unusual Options Activity
Vertex Pharmaceuticals is a global biotechnology ... Next earnings are expected to be released in 7 days. Benzinga Edge's Unusual Options board spots potential market movers before they happen.
Reuters20d
Vertex Pharmaceuticals Inc
US FDA approves Vertex's non-opioid painkiller Future of Healthcategory· January 31, 2025 Britain's National Health Service (NHS) will provide a cutting-edge gene therapy that aims to cure sickle ...
health.economictimes.indiatimes18d
UK health system to offer cutting-edge gene therapy for sickle cell disease
will provide a cutting-edge gene therapy that aims to cure sickle cell disease, the National Institute for Health and Care Excellence (NICE) said on Friday. The therapy from Vertex Pharmaceuticals ...
Nasdaq15d
Vertex Pharmaceuticals Unusual Options Activity
Vertex Pharmaceuticals Option Volume And Open ... Smart Money on the Move Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money ...